Gulsen Kama - Sep 18, 2023 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role: Chief Financial Officer
Signature: /s/ Jonathan V. Dixon, Attorney-in-Fact
Stock symbol: BNGO
Transactions as of: Sep 18, 2023
Transactions value $: $0
Form type: 4
Date filed: 9/20/2023, 05:21 PM
Previous filing: Sep 20, 2023
Next filing: Jun 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BNGO	Stock Option (Right to Buy)	Award	$0	+106K		$0.00	106K	Sep 18, 2023	Common Stock	106K	$3.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to the option shall vest and become exercisable on September 11, 2024, and the remaining shares shall vest in a series of 36 successive equal monthly installments measured from September 11, 2024, subject to Reporting Person's Continuous Service (as defined in the Company's 2020 Inducement Plan, as amended) through each such applicable vesting date and the terms of the Company's 2020 Inducement Plan, as amended.

Content

25% of the shares subject to the option shall vest and become exercisable on September 11, 2024, and the remaining shares shall vest in a series of 36 successive equal monthly installments measured from September 11, 2024, subject to Reporting Person's Continuous Service (as defined in the Company's 2020 Inducement Plan, as amended) through each such applicable vesting date and the terms of the Company's 2020 Inducement Plan, as amended.